Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK Manufacturing Consolidation Has Helped GMP Compliance, Firm Says

Executive Summary

GlaxoSmithKline's manufacturing streamlining has helped the company avoid trouble during the recent round of FDA good manufacturing practices enforcement, CEO J.P. Garnier told investors Oct. 23
Advertisement

Related Content

GSK Puerto Rico Plant Under Investigation By FDA; Received Warning In 2002
GSK Puerto Rico Plant Under Investigation By FDA; Received Warning In 2002
Paxil OS GMP Concerns Resolved By Year-End, GSK Says After Warning Letter
Paxil OS GMP Concerns Resolved By Year-End, GSK Says After Warning Letter
Glaxo/SB Supply Chain Alignment Will Ease Second Merger Attempt - Garnier
Glaxo/SB Supply Chain Alignment Will Ease Second Merger Attempt - Garnier
Advertisement
UsernamePublicRestriction

Register

PS040690

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel